Literature DB >> 10574508

Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes.

J P Horcajada1, M García-Bengoechea, G Cilla, P Etxaniz, E Cuadrado, J I Arenas.   

Abstract

In order to analyse the prevalence and significance of cryoglobulinaemia in patients with chronic hepatitis C virus (HCV) infection and the possible relationship of cryoglobulinaemia with the genotypes of HCV, we studied 89 patients with chronic HCV infection, 42 healthy controls and 22 patients with alcoholic cirrhosis. The patients with HCV were divided into three different groups according to the presence of cirrhosis and alanine aminotransferase levels. Moreover, in 20 patients with HCV and cryoglobulinaemia, HCV RNA sequences were quantified in serum and in cryoprecipitate. Cryoglobulins were detected more frequently in patients with chronic HCV infection than in healthy controls (42.6% vs. 4.7%; P<0.0001). Cryoglobulins were present in 68.4% of patients with HCV-related cirrhosis, which was nearly twice the figure in noncirrhotic HCV-infected patients and alcoholic cirrhotic patients. There were no differences in age, sex, aminotransferase levels or HCV genotype distribution in HCV-infected patients with or without cryoglobulinaemia. Only 13% of patients with chronic HCV infection and cryoglobulins showed symptoms of cryoglobulinaemia. There was a linear association between HCV RNA concentration in sera and in cryoprecipitates (P<0.0005). Patients with chronic HCV infection had a high prevalence of cryoglobulinaemia, especially in advanced forms of the disease, but clinical findings are few. There was no relationship with the genotype of HCV. The presence of HCV RNA in cryoprecipitates supported the hypothesis on the aetiological role of HCV in mixed cryoglobulinaemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574508     DOI: 10.3109/07853899908995902

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  9 in total

1.  Mixed cryoglobulinemia: an unusual presentation of hepatitis C.

Authors:  Donald Mebust
Journal:  Perm J       Date:  2013

2.  Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins.

Authors:  B-N Pham; M Martinot-Peignoux; M-P Ripault; N Boyer; V Levy; P Marcellin
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

3.  Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy.

Authors:  Paolo Conca; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 4.  Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

Authors:  Chalermrat Bunchorntavakul; Robert Mitrani; K Rajender Reddy
Journal:  J Clin Exp Hepatol       Date:  2017-12-07

5.  A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal.

Authors:  Corry van den Bosch
Journal:  Adv Hematol       Date:  2011-11-29

Review 6.  [Vasculitis associated with viral infections].

Authors:  Pascal Cohen; Loïc Guillevin
Journal:  Presse Med       Date:  2004-11-06       Impact factor: 1.228

7.  Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis.

Authors:  Deanna M Santer; Mang M Ma; Darren Hockman; Abdolamir Landi; D Lorne J Tyrrell; Michael Houghton
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

8.  Mixed cryoglobulinemia-associated Sjögren's syndrome leading to spontaneous rupture of the kidney: a case report.

Authors:  Intissar Haddiya; Hakim Hamzaoui; Zitouna Alhamany; Fatime-Zohra Berkchi; Hakima Rhou; Loubna Benamar; Naima Ouzeddoun; Rabea Bayahia
Journal:  Int Med Case Rep J       Date:  2016-03-23

Review 9.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.